Cite
HARVARD Citation
Terpos, E. et al. (n.d.). Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates. American journal of hematology. 94 (4), pp. 400-407. [Online].